![Yi Larson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 30/06/2026
La Sra. Yi Larson es directora independiente de Olema Pharmaceuticals, Inc. Forma parte del Consejo de Administración de Olema Pharmaceuticals, Inc. y de Rayzebio, Inc. La Sra. Larson trabajó anteriormente como Directora Financiera y Vicepresidenta Ejecutiva en Turning Point Therapeutics, Inc. Se licenció en The Wharton School of the University of Pennsylvania, se graduó en el Massachusetts Institute of Technology y obtuvo un MBA en The Wharton School of the University of Pennsylvania.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LIANBIO -.--% | 10/04/2023 | 0 ( -.--% ) | - $ | 30/06/2026 |
| 18/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 06/04/2021 |
Expedition Therapeutics, Inc.
 Expedition Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel treatments for inflammatory and respiratory diseases | Director Ejecutivo | 01/04/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| RAYZEBIO, INC. | Director/Miembro de la Junta | 26/02/2024 |
| LIANBIO | Director Financiero/CFO | 19/12/2023 |
| TURG POIN | Director Financiero/CFO | 31/03/2021 |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Expedition Therapeutics, Inc.
Expedition Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel treatments for inflammatory and respiratory diseases | Health Technology |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
LianBio
 LianBio BiotechnologyHealth Technology Operates as a biotechnology company focused on bringing paradigm-shifting medicines to patients | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
